G1 Therapeutics, Inc. Profile Avatar - Palmy Investing

G1 Therapeutics, Inc.

G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease c…

Biotechnology
US, Research Triangle Park [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of GTHX's Analysis
CIK: 1560241 CUSIP: 3621LQ109 ISIN: US3621LQ1099 LEI: - UEI: -
Secondary Listings
GTHX has no secondary listings inside our databases.